News | February 23, 2012

St. Jude Children’s Hospital Selects Hitachi to Supply Proton Beam Therapy System

February 23, 2012 — Hitachi Ltd. announced that it entered into an agreement with St. Jude Children’s Research Hospital to provide its proton beam therapy (PBT) system. This technology has spot scanning capability for treating certain forms of cancer. The agreement includes PBT system maintenance for 10 years following completion of the systems’ installation.

The system will be installed at St. Jude Children’s Research Hospital in Memphis, Tenn. There will be three treatment rooms, two with rotating gantry systems and one with a fixed horizontal beam. The installed PBT system will be a compact design with a footprint approximately 40 percent smaller than that of conventional systems. Construction for facilities has begun and treatment using is expected to be offered in the fall of 2015.

William Evans, Pharm.D, CEO of St. Jude Children’s Research Hospital said, “by bringing the technology to our campus, we will become the first center in the country offering this cutting-edge therapy solely for the purpose of treating children with brain tumors and other pediatric cancers. Currently, we ensure our patients needing this therapy receive it through collaboration with other institutions, but having the technology available here at St. Jude will enable a new level of service and convenience for our patients. In addition, it takes advantage of recent advances in the technology and will allow integration with our cutting-edge research programs.”

Tatsuro Ishizuka, vice president, executive officer, president and CEO of power systems company, Hitachi Ltd. said, "it is an honor to have our technology recognized and to be selected to provide our PBT system. We are especially proud of the fact that our system has been selected by the premier pediatric oncology hospital and will be dedicated to the treatment of children.”

PBT is an advanced type of radiation therapy used to treat adults and children with cancer. Protons, the atomic nucleus of hydrogen, are accelerated to high speeds and focused to deposit their energy in tumors. PBT has been shown to improve the quality of life for cancer patients since patients experience less radiation exposure to normal tissues and fewer side effects. In most cases, adults and children can continue with their normal daily activities while undergoing out-patient treatment.

Since the 1990’s, interest in proton beam therapy as a form of cancer treatment has been rapidly increasing in the United States, given the growing demand for more advanced and less detrimental treatment modalities, interest in proton therapy is on the rise, with more and more hospitals and cancer treatment facilities venturing into this area. In December 2007, for the first time in the United States, Hitachi cleared the FDA Premarket Notification Special 510(k) for spot scanning irradiation technology.

For more information: www.stjude.org, www.hitachi.com

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init